French patients on daily hemodialysis: clinical characteristics and treatment trajectories. Issue 1 (December 2016)

• Record Type: Journal Article
• Authors: Pladys, Adélaïde; Bayat, Sahar; Kolko, Anne; Béchade, Clémence; Couchoud, Cécile; Vigneau, Cécile
• Is Part Of: BMC nephrology. Volume 17:Issue 1(2016)
• Page Start: 1
• Page End: 10
• Publication Date: 2016-12
• Subjects: Daily hemodialysis -- End stage renal disease -- Patient profiles -- Patients trajectories -- REIN registry; Kidneys -- Diseases -- Periodicals; 616.61005
• DOI: 10.1186/s12882-016-0306-7
• Languages: English
• ISSNs: 1471-2369

Abstract

Abstract Background Increasing the weekly frequency of hemodialysis sessions has positive effects, on the control of several biological data of patients. However, knowledge about Daily HemoDialysis (DHD) practices is limited in France. The aim of the present study was to describe the characteristics and treatment trajectories of all French patients undergoing DHD. Methods All patients older than 18 years who started DHD between 2003 and 2012 in France were included and followed until December 31, 2013. The patients' demographic and clinical characteristics and treatment modalities were extracted from the French Renal Epidemiological and Information Network (REIN) registry. Results During the inclusion period, 753 patients started DHD in France. Based on their median age (64 years), patients were classified in two groups: "old" group (≥64 years) and "young" group (<64 years). Patients in the old group had more comorbidities than in the young group: 48 % had diabetes (vs 29 % in the young group), 17 % an active malignancy (vs 10 %) and 80 % ≥1 cardiovascular disease (vs 41 %). Concerning patients' treatment trajectories, 496 (66 %) patients started with another dialysis before switching to DHD and 257 (34 %) directly with DHD. At the end of the follow-up, 69 % of patients in the old group were dead (27.4 % in the young group) and kidney transplantation was more frequent in the young group (30.4 % vs 0.5 %). Conclusion In France, DHD is proposed not only to young in rather good clinical conditions and waiting for kidney transplantation, but also to old and frail patients with higher mortality.